Location History:
- Davis, CA (US) (2015 - 2022)
- Sacramento, CA (US) (2017 - 2022)
Company Filing History:
8 out of 15,488 
3 out of 896 
1 out of 1,572 
Years Active: 2015-2022
Title: Inventor Spotlight: Chong-Xian Pan
Introduction
Chong-Xian Pan is an accomplished inventor based in Davis, CA, with an impressive portfolio of ten patents to his name. His work primarily focuses on innovative methods that enhance cancer treatment protocols, showcasing his dedication to advancing medical science and improving patient outcomes.
Latest Patents
Among his most notable inventions are the following:
1. **Methods for cytotoxic chemotherapy-based predictive assays** - This invention encompasses methods, systems, and kits designed to determine the therapeutic effectiveness or toxicity of cancer-treating compounds that bind to DNA. It provides physicians with a diagnostic tool to categorize cancer patients into distinct groups based on their likelihood of responding positively to specific treatments after administering a microdose of therapeutic composition.
2. **Methods of improving cancer chemotherapy** - This patent outlines methods and compositions aimed at prolonging survival and inhibiting tumor growth in cancer patients undergoing chemotherapy. By incorporating an inhibitor of soluble epoxide hydrolase (sEHi) and a non-steroidal anti-inflammatory drug (NSAID), the methods seek to decrease toxicity and adverse side effects commonly associated with chemotherapeutic regimens.
Career Highlights
Chong-Xian Pan has significantly impacted the field of cancer research through his tenure at prominent institutions. Notably, he has contributed to the University of California and served in the U.S. Government, particularly represented by the Department of Veterans Affairs. His work has placed him at the forefront of cancer treatment innovations, leading to notable advancements in therapeutic methods.
Collaborations
Throughout his career, Pan has collaborated with esteemed professionals, including Hongyong Zhang and Kit S. Lam. These partnerships have not only enhanced his research capabilities but have also fostered a collaborative environment conducive to innovation in cancer therapies.
Conclusion
Chong-Xian Pan exemplifies the spirit of innovation in the medical field, with his work having the potential to transform cancer treatment practices. His numerous patents and collaborations highlight a commitment to improving patient care and pushing the boundaries of medical science. As he continues his work, the impact of his inventions will likely resonate within both the medical community and the lives of cancer patients.